Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The phase 2 trial published in The New England Journal of Medicine in 2023 enrolled adults with obesity without type 2 diabetes and demonstrated dose-dependent weight loss of up to 24.2% of body weight at the highest dose over 48 weeks results that attracted considerable scientific and media attention
Job loss, unexpected expenses, or changes in financial circumstances may make continued treatment temporarily impossible
First GLP-1 tablet for weight loss approved in the UK
A medical evaluation will help determine if this treatment suits an individuals health history and existing conditions
Our study using 2020 to 2025 Medicare data showed dramatic increases in out-of-pocket costs for GLP-1s, because of insurers reactions to the 2022 Inflation Reduction Act
Your stomach will thank you later
:max_bytes(150000):strip_icc()/GettyImages-1807240274-2c7c39cb23f34a97bb2d8620911c343d.jpg)
US$ 21.31
US$ 29.10
US$ 26.96
US$ 25.82
.webp)
US$ 29.64
US$ 29.39
